News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Elisa Agostinetto: Must-read by Marleen Kok on the limitations of KEYNOTE-522
Collage photo of Elisa Agostinetto and Marleen Kok
Jul 26, 2024, 00:03

Elisa Agostinetto: Must-read by Marleen Kok on the limitations of KEYNOTE-522

Elisa Agostinetto shared on X:

“Out in JCO a must-read by Marleen Kok on the limitations of KEYNOTE-522.

To control (financial) toxicity, agencies must limit trial designs where the relative contribution of each phase of treatment (pre vs. postop) cannot be established.”

Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer published in JCO

Autors: Marleen Kok, Robbert-Jan Gielen,  Sylvia Adams, Jochen K. Lennerz, Priyanka Sharma, Sibylle Loibl, Erin Reardon, Gabe Sonke, Sabine Linn, Suzette Delaloge, Denis Lacombe, Tim Robinson, Sunil Badve, Miguel Martin, Justin M. Balko, Michail Ignatiadis, Giuseppe Curigliano, Antonio C. Wolff, Elizabeth A. Mittendorf, Sherene Loi, Lajos Pusztai, Sara M. Tolaney, and Roberto Salgado

Must-read by

Source: Elisa Agostinetto/X

Elisa Agostinetto is a Clinical Research Fellow at the Institute Jules Bordet in Brussels, Belgium. She is also a Resident in Medical Oncology at Humanitas Research Hospital in Milan, Italy. Agostinetto specializes in Breast Cancer and Immuno-Oncology.

Antonio C. Wolff Denis Lacombe Elisa Agostinetto Elizabeth A. Mittendorf Erin Reardon Gabe Sonke Giuseppe Curigliano JCO Jochen K. Lennerz Justin M. Balko KEYNOTE-522 Lajos Pusztai Marleen Kok Michail ignatiadis Miguel Martin Priyanka Sharma Robbert-Jan Gielen Roberto Salgado Sabine Linn Sara M. Tolaney Sherene Loi Sibylle Loibl Sunil Badve Suzette Delaloge Sylvia Adams Tim Robinson
Special Coverage
Insight
Nov 15, 2024, 02:40
Patrick Hwu was Named one of the 2024 Florida 500 for Leadership in Medicine and Cancer Research
Blog
Nov 14, 2024, 17:57
European Cancer Organisation's Memorandum of Understanding with UNFPA
Blog
Nov 14, 2024, 17:51
Research is for everyone. Every voice and experience matters - Young Lung Cancer Initiative
Blog
Nov 14, 2024, 17:48
Marco Donia: Pleased to be Co-chairing with Timothée Olivier in an educational session at ESMOImmuno24
Blog
Nov 14, 2024, 17:46
Dinesh Pendharkar: Continuing mission of Sickle cell disease and Cancer
Blog
Nov 14, 2024, 17:46
Abstracts submissions open for MASCC25
Blog
Nov 14, 2024, 17:42
Shahana Banerjee: Reimagining Healthcare with Sachin H. Jain
Blog
Nov 14, 2024, 17:32
Nandita Kotwani: KidsX collaboration with the CancerX Moonshot 2025 Accelerator program
Blog
Nov 14, 2024, 17:23
Douglas Flora: UK Markey Cancer Center Affiliate Network 2024 Cancer Care Conference
Blog
Nov 14, 2024, 17:19
Cate OReilly: Sally Werner on the transformative impact of supportive cancer care
Blog
Nov 14, 2024, 17:14
Petra Ibum Adjah: Men's Health Matter
Blog
Nov 14, 2024, 16:54
Roupen Odabashian: Looking for medical students or residents interested in conducting AI research in oncology